Emergent BioSolutions to Participate in Investor Conferences
August 23 2021 - 4:05PM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s senior management team will participate in the
following investor conferences:
- Three Part Advisors IDEAS Midwest
Conference August 25-26, 2021 Pre-recorded
presentation available on August 26; 1-on-1 meetings on August
26
- Wells Fargo 2021 Virtual Healthcare
Conference September 9-10, 2021 Fireside chat on
September 9 at 9:20 am ET; 1-on-1 meetings all day
- Morgan Stanley 19th Annual Global Healthcare
Conference September 9-10 & 13-15, 2021 Fireside
chat on September 9 at 3:30 pm ET; 1-on-1 meetings all day
- Baird’s 2021 Global Healthcare
Conference September 14-15, 2021 Fireside chat on
September 14 at 4:55 pm ET; 1-on-1 meetings all day
- Singular Research Compelling Values
Webinar September 16, 2021 Company presentation
schedule will be posted on website
- Cantor 2021 Virtual Global Healthcare
Conference September 27-30, 2021 Fireside chat on
September 27 at 4:00 pm ET; 1-on-1 meetings all day
For conferences where a presentation is planned, the company’s
webcast presentation may include a discussion of the company's
recent business developments as well as its financial results and
guidance. The webcast will be available both live, if possible, and
by replay, and will be accessible from the Emergent website.
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information, visit our website and
follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G. BurrowsVice
President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigDirector, Media
Relationshartwigm@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024